Patient Populations

Conversation Starters: Solutions to Overcome Health Disparities in Latinx Communities

Language and cultural barriers are often a challenge when treating underserved Hispanic populations, which was only exacerbated by the COVID-19 pandemic. However, Ricardo Correa, MD, EdD, and Licy L. Yanes Cardozo, MD, tell Endocrine News how to improve care delivery to these patients, and how the solutions could be simpler than you think. Last month,...

Endocrine Society Experts Recommend Individualized Approach to Use of Telehealth

Policy perspective explores factors to maximize effectiveness of telehealth Following rapid growth during the COVID-19 pandemic, telehealth visits are expected to remain an important part of endocrine care, according to a new Endocrine Society policy perspective published in The Journal of Clinical Endocrinology & Metabolism. Health care providers need to consider a variety of...

Excessive Smartphone Screen Time Linked to Earlier Puberty Onset

Exposure to blue light through regular use of tablets and smartphones may alter hormone levels and increase the risk of earlier puberty, according to data from a rat study presented last month at the 60th Annual European Society for Paediatric Endocrinology Meeting in Rome. Longer duration of blue light exposure was associated with earlier puberty...

A Beautiful Day in the Neighborhood: EndoCares Atlanta Saves Immigrant and Refugee Lives

During ENDO 2022, the Endocrine Society made a community-wide “house call” with a flagship EndoCares® event that brought care and compassion to an underserved population. On Saturday June 11, the atmosphere at the Clarkston Community Center in Clarkston, Ga., could only be described as festive. The red brick building was filled with neighbors visiting...

Cost of Mental Health Disorders Linked with Polycystic Ovary Syndrome Almost $6 Billion in 2021

A study presented at ENDO 2022 laid bare the excess direct healthcare costs of mental health disorders associated with polycystic ovary syndrome (PCOS) in the United States, finding those costs reached almost $6 billion in 2021. The authors of the study point out that PCOS affects one in seven reproductive-aged women worldwide, and represents a...

Clearing Hurdles: How Clinicians and Patients Can Create Their Own Winning Team

Amidst of the throngs of ENDO 2022 attendees, Olympian Gail Devers took centerstage to discuss living with and overcoming Graves’ disease and thyroid eye disease. She teamed up with endocrinologist Eve D. Bloomgarden, MD, to tout the importance of patient/physician teamwork and why patients need to champion their own healthcare. In a lot of ways,...

Seeing the Evidence: ENDO 2022 Poster Presentations Shed New Light on COVID-19’s Impact on Endocrine Conditions

ENDO 2022 was once again a hotbed of new research as people convened in person and online from around the world. Here, we look at two international researchers who shared their COVID-19 studies in poster presentations that looked at the pandemic’s impact on thyroid function, thyroid dysfunction, and the impact on women’s ovulatory cycles. ENDO...

Study Links Diabetes and Worse Outcomes in Long-Term Survivors of Metastatic Breast Cancer

Women who are longer-term survivors of metastatic breast cancer may have a worse survival rate if they have diabetes and poorly controlled blood sugar levels, according to a study presented at ENDO 2022. The authors of the study point out that a well-established relationship between diabetes and breast cancer exists, but it’s still unclear how...

Patient Populations

Endocrine news on twitter